** U.S.-listed shares of EDAP TMS S.A EDAP.O drop
~15%premarket after French medical device co's follow-on prices
** Co, which makes ultrasound devices to treat prostate
cancer, late Thurs sold ~2.7 mln ADSs at $7.50 urn:newsml:reuters.com:*:nGNX3QZkyw
** Offering price is 12.5% discount to stock's last close
** Jefferies sole bookrunner
** Co has ~33.47 mln shares outstanding for $287 mln market
cap
** EDAP up 43% YTD, including 26% gain since this quarter
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))